GBL stock heads into the open after a flat Brussels close
Published on 09/17/2026 at 07:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GBL stock closed at EUR 253.00 on Euronext Brussels on September 16, 2026, showing a 0.0% change from the prior session based on the latest available Brussels data. In the same session, peer Sofina closed at EUR 253.00 on Euronext Brussels, down 0.94%, underlining the relatively steadier profile of GBL on that day. The Brussels market itself saw selective weakness among investment holding names in that session.
September 16, 2026 in numbers
Groupe Bruxelles Lambert SA (ISIN BE0003797140) ended trading on September 16, 2026 at EUR 253.00 on Euronext Brussels, with the closing level matching the prior close, indicating a neutral day for the shares. Sofina, another Brussels-listed investment company, finished the same session at EUR 253.00, down 0.94% from EUR 255.40, according to data for United Kingdom and Belgium shares at Euronext Brussels. The move in Sofina was reported in a corporate-news wrap by Ad-hoc-news, highlighting a modest decline for that peer while GBL held steady. A separate corporate-news report from Ad-hoc-news noted that GBL stock held steady as attention remained on its bid-related exposure to Recordati, framing the session as one of stability despite corporate deal headlines.
Deal focus today
Today, GBL continues to be closely watched in connection with the ongoing bid story around Italian pharmaceutical group Recordati, which has been a key theme in recent coverage of the company. As Ad-hoc-news reported on September 16, 2026, the market has been assessing how the bid for Recordati could influence valuation and strategic options for GBL, and that theme is likely to remain central ahead of today’s Euronext Brussels session. Broader European markets will also be gauging corporate deal activity and healthcare-sector sentiment, factors that can feed into trading dynamics for investment holdings such as GBL today.
